All clinical stage biotechs burn cash. No surprise! We should all be worried if PMCB were not raising a war chest. I do wish there was a more specific explanation of what the proceeds will be used for. Instead of "general working capital", how about "cost to fund pending clinical trials". Also, acquisitions are great for press releases, but what are our priorities here .. acquisitions, or trials? "Pivotal trial" is not even mentioned in the capital raise... why?
RE: Pump & Dilute scheme. I just have a real hard time believing that all the credentialed medical talent acquired in 2016 and 2017 are actually cohorts to management in a scheme to steal money from the hands that are feeding them. At the same time, Why are we still placing shares at deep discounts? WTF! The board better fix that or the community will never gain respect or confidence in the stock. How about we start flexing some gosh darn muscle around here!
Message to the new guy .... Where is our free money? Forget about giving shares away ... get us some Gosh Darn grants or contributions! This is cancer we are talking about... there are lots of foundations that would like to be connected and in some way responsible for "The cure". Get the free money, and you'll get premiums on your placements.
GTLA!
Market Data 
Markets 
AI
